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ABSTRACTSIntroduction: An initial study demonstrated signiﬁcantly increased risk of
malignant diagnosis in those aged 60 or over diagnosed with idiopathic
venous thrombo-embolism. This follow up survey investigate whether fast
track pathways screen for potential malignancy in idiopathic deep venous
thrombosis (DVT).
Methods: A telephone survey contacted all hospital medical trusts
advertising in a single edition of the BMJ careers. The survey identiﬁed
trusts’ use of fast-track pathways for DVT, whether nurse led, physician
involvement and follow up procedures for idiopathic cases.
Results: 52 trusts responded (91%). All trusts conducted some form of
rapid access fast track pathway for DVT referral and investigation. 47 (94%)
used nurse led pathways, 46 (88%) had little or no physician contact once
referred to the pathway. Of 52 responses, 2 (3.6%) had formal guidelines for
in-depth assessment of patients labelled idiopathic aged 60 or over by a
physician.
Conclusions: Fast-track DVT pathways require greater physician input to
screen cases, looking for possible occult malignancy as an underlying cause
for VTE. Current moves to community based nurse led pathways may
result in a missed opportunity to diagnose and intervene in malignancy at
an earlier stage.
0070: UPTAKE OF CAROTID ARTERY STENTING IN ENGLAND AND SUB-
SEQUENT VASCULAR ADMISSIONS: AN APPROPRIATE RESPONSE TO
EMERGING EVIDENCE?
Angeline Hwee Yin Lee 1, John Busby 1, Marcus J. Brooks 2,
William Hollingworth 1. 1University of Bristol, Bristol, UK; 2Bristol Royal
Inﬁrmary, Bristol, UK.
Aims:We report the uptake, length of stay and vascular readmission rates
of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in the
English National Health Service (NHS) between 2006 and 2009.
Methods: This is a retrospective cohort study based on Hospital Episode
Statistics (HES) inpatient data on CEA (n¼15996) and CAS (n¼632). We
analysed trends in procedure use over time and used ordinary least
squares multivariate analysis and Cox proportional hazards regressions to
evaluate patient, clinical and organisational characteristics associated with
longer length of stay for revascularisation and higher rates of readmission
for vascular events.
Results: CASmade up less than 5% of carotid revascularisation procedures;
there was no trend for increasing use over time. CAS patients had a 35%
(95% CI: 30, 39) shorter stay in hospital than CEA patients. However they
were more likely to be readmitted following stroke, transient ischaemic
attack (hazard ratio 1.52 [95% CI: 1.19, 1.94]) and myocardial infarction
(hazard ratio 1.54 [95% CI: 1.08, 2.21]).
Conclusions: Despite the early promise of CAS and numerous RCTs eval-
uating efﬁcacy, it has not been rapidly adopted in England. Cautious
adoption may be appropriate given the ﬁnely balanced evidence regarding
subsequent myocardial infarction, stroke and cost-effectiveness.
0087: LAPAROSCOPIC LIGATION OF TYPE II ENDOLEAKS POST ENDO-
VASCULAR ANEURYSM REPAIR (EVAR): CURRENT EVIDENCE FOR PRAC-
TICE e A SYSTEMATIC REVIEW
Thomas Marjot 1, Andrew Choong 1, Kirtan Patel 2, Vamsee Bhrugubanda 2,
Stuart Gould 3, Sophie Renton 1. 1Outer North West London Regional Vascular
Unit, Northwick Park Hospital, London, UK; 2 Imperial College School of
Medicine, London, UK; 3Department of General Surgery, Northwick Park
Hospital, London, UK.
Aims: Type II endoleak complicates 10-25% of EVAR. Although the clin-
ical signiﬁcance of type II endoleak remains contentious, the strategies
used for its management have continued to expand. We systematically
review the literature and comprehensively appraise the effectiveness of
laparoscopic intervention in the management of this common
complication.
Methods: Review methods were according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.
Published literature from ﬁve electronic databases was searched.
Studied outcomes included patient demographic, aneurysm type,
graft type, endoleak type, previous endovascular embolization
attempted, vessel ligated laparoscopically, length of stay and follow
up duration.Results: 9 studies representing 20 patients were investigated. Mean age
was 74.4. All patients were ASA II and above. All underwent standard
infrarenal EVAR. 16 patients suffered a type II endoleak from the inferior
mesenteric artery. 60% (12/20) patients had unsuccessful or were unsuit-
able for embolization. 30-day mortality was 5%.
Conclusions: Direct laparoscopic ligation of feeding vessels causing type II
endoleak is particularly useful in cases where standard endovascular
embolization has failed. It is associated with low 30-day mortality and
should be considered an essential tool in the armamentarium of the
vascular and laparoscopic surgeon.
0095: PROFILING OF MOISTURE STATUS IN VENOUS LEG ULCERS
Joshua Burke 1, Mustafa Khanbhai 2, Charles McCollum 2,
Patricia Connolly 3, Eileen Temple 3. 1University of Manchester, Manchester,
UK; 2Univeristy Hospital of South Manchester, Manchester, UK; 3Ohmedics,
Glasgow, UK.
Aims: The aim of this study was to assess wound moisture levels and to
evaluate correlation with Venous Leg Ulcer (VLU) healing.
Methods: Seven patients were recruited over 21 days and their VLUs were
classiﬁed; class A (healthy, healing) to class D (unhealthy, not healing).
Ulcer moisture levels were recorded bi-weekly using a non-invasive
wound moisture monitoring system [dry(1) to wet(4)] without disturbing
compression regimes. Digital Planimetry calculated healing rate (% change
in ulcer size/week).
Results: Mean (+SEM) age was 72 years (+ 4.3). By day 21, 57% (n¼4) of
patients with VLUs had completely healed. Class A ulcer was 100% predic-
tive of 100% granulation and ‘drop' reading of 1. There was correlation be-
tween ulcers with greater surface area and higher moisture levels rs¼0.4,
p<0.05. However, ulcers with a faster healing rate (40%) had greater
moisture content compared to slower-healing ulcers (<40%), p<0.05.
Conclusions: We have demonstrated that moisture content may play a
role in VLU healing rate. Class A ulcers correlate well with moisture and
granulation, indicating; dry readings are found at complete granulation/
healing. Further work is required to elucidate whether artiﬁcially
increasing VLU moisture content has a role in hastening healing in class C,
D and slow-healing ulcers.
0098: THE OUTCOME OF ENDOVASCULAR TREATMENT FOR COMPLI-
CATED ACUTE DISSECTION IS DEPENDENT UPON TREATMENT INDICA-
TION: THE NEED FOR CLEAR GUIDELINES
Elizabeth Rajiah 2, Rachel E. Clough 1, Kevin Mani 1, Susie Key 1,
Tarun Sabharwal 1, Richard Salter 1, Irfan Ahmed 1, Andrew McGrath 1,
Panos Gkoutzious 1, Peter Taylor 1. 1Guy's & St Thomas's NHS Foundation
Trust, London, UK; 2King's College London, London, UK.
Objective: Thoracic endovascular aortic repair (TEVAR) is the treatment of
choice for complicated acute type B dissection. However the indications for
intervention vary widely in their severity. We investigated the effect of
treatment indication on outcome.
Methods: All patients treated for acute complicated type B dissection at a
tertiary referral centre between January 2000-July 2011 were identiﬁed
froma prospective TEVAR database. Patientswere categorised based on the
indication for treatment: rupture, end organ ischaemia and persistent pain.
Death, stroke and paraplegiawere regarded asmajor adverse events (MAE).
Results: 43 patients were identiﬁed. The perioperative rate of MAEs was
27.9% (death 11.6%, stroke 11.6%, paraplegia 9.3%). The MAE rate was 25.0%
for those treated for rupture, 46.7% for end organ ischaemia and 8.3% for
persistent pain. Persistent pain as an indication was associated with a
better outcome compared with end organ ischaemia (p¼0.04) but not
compared with aortic rupture (p¼0.36).
Conclusion: Treatment indication affects the outcome of TEVAR for
complicated type B aortic dissection. Patients with persistent pain have a
better outcome than those with end-organ ischaemia. The mode of pre-
sentation and treatment indication should be used for risk stratiﬁcation of
patients with complicated acute type B aortic dissection.
0112: TEMPORAL ARTERY BIOPSIES: ARE WE TAKING LONG ENOUGH
SPECIMENS?
Ashok Gunawardene, Harvey Chant. Royal Cornwall Hospital, Truro, UK.
Introduction: Temporal artery biopsy is the "gold standard" investigation
for giant cell arteritis. The Royal College of Rheumatologists guidelines
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ABSTRACTSrecommend taking at least 10mm in length in order to minimise the false
negative rate.
Methods: A retrospective audit was carried out for biopsies performed
over a 12 month period at a single centre by the vascular surgery
department. Specimen length and histological ﬁndings were reported by
Consultant Histopathologists.
Results: 52 biopsies were included in the study and 35/52 (67.3%) were
10mm or greater in length. The mean specimen length was greater in
positive biopsies (15.8mm) compared with negative biopsies (10.9mm)
and increased with grade of surgeon, SHO (n¼6), 9.7mm; SpR (n¼36),
10.39mm; Consultant (n¼9), 11.3mm. Themean ESR was higher in patients
whose specimens were less than 9mm (n¼19), 45.1 compared to those
with specimens 10mm or greater (n¼33), 36.8. Specimens less than 9mm
were more likely to be "non-arterial tissue" (21.1%) compared with spec-
imens 10mm or greater (3.0%).
Conclusion: The majority of specimens were 10mm or greater in length
but there is still room for improvement in practice. The more experienced
surgeons took longer biopsies, and shorter biopsy specimen length was
associated with non-arterial tissue sampling and raised ESR.
0131: SURGICAL AND FUNCTIONAL OUTCOMES AFTER THORACIC
OUTLET SYNDROME DECOMPRESSION VIA SUPRACLAVICULAR
APPROACH: A 10-YEAR SINGLE CENTRE EXPERIENCE
Jakub Kaczynski, Steve Atherton, Louis Fligelstone. ABM University Health
Board, Vascular Surgery Department, Morriston Hospital, Swansea, UK.
Aim: The aimwas to assess surgical and functional outcomes after surgical
decompression of the thoracic outlet using the Disabilities of the Arm,
Shoulder and Hand (DASH) questionnaire.
Methods: A retrospective review of all thoracic outlet syndrome (TOS)
cases operated between 2002- 2012. The pre and post operative DASH
questionnaire scores were recorded.
Results: Forty four patients (88%) completed pre and post operative DASH
questionnaire. Mean age was 42+ 10.78 years and 37 were women. There
were 40 elective and 4 emergency operations. Decompressive procedures
consisted of an excision of the cervical (n¼11) or ﬁrst rib (n¼23), combined
cervical and ﬁrst rib excision (n¼10), scalenectomy (n¼42) and division of
soft tissue (n¼24). Post operative complications included wound infection
(n¼1), phrenic nerve traction injury (n¼2) and pleural entries (n¼12).
Mean follow up was 11.7+ 15.4 months. The most marked post operative
improvement was noted in arterial TOS with mean delta change of 36.99+
22.72 (p¼0.005), followed by venous TOS (26.22+ 16.89, p¼0.026) and
neurogenic TOS (18.64+ 21.07, p¼0.015). Thirty nine (78%) patients re-
ported the return of upper limb function.
Conclusions:Careful selection of patientswithmeticulous surgical technique
can produce excellent surgical and functional outcomes in all TOS types.
0164: PROPATEN (HEPARIN BONDED) GRAFTS FOR HAEMODIALYSIS AC-
CESS: IS THERE ANY ADVANTAGE?
Usman Khalid, Paula Davies, Kamran Mohiuddin, Chris Davies,
Justin Woolgar. Department of Vascular Surgery, Morriston Hospital,
Swansea, UK.
The use of an Arterio-venous synthetic graft (AVG) for haemodialysis ac-
cess is often necessary if the veins become thrombosed or are of small
calibre. The aim of this audit was to determine the outcomes of the hep-
arin-bonded Propaten (WG Gore Phoenix Arizona) graft.
All patients who had Propaten AVG inserted between January 2011 and
December 2012 were included in this study. Theatre records and clinical
notes were interrogated retrospectively to collect data on indication for
Propaten AVG, its location, patency and any complications.
Twenty ﬁve patients had Propaten AVG inserted over the 2-year period,
68% were female, and the median age was 66 (22-86). Indication for the
use of AVG was the lack of any suitable veins (either thrombosed or
diameter less than 3mm). The most common location was brachio-basilic
AVG (60%). 56% of the patients were successfully dialysing using these
AVG's at the time of study or time of death. There was primary failure in
28% and one graft was removed at 6 months due to infection.
Patency rates are comparable to other synthetic grafts and the heparin
bonded Propaten graft appears to confer no advantage. Furthermore there
is a signiﬁcant cost implication with the use of Propaten.0245: IS DUPLEX ULTRASOUND ENDOLEAK SURVEILLANCE AFTER EVAR
COST EFFECTIVE? A COMPARISON WITH EUROPEAN SOCIETY OF
VASCULAR SURGERY GUIDELINES
Jon Grifﬁn, Rachel S. Williams, Mark Pemberton. Queen Alexandra Hospital,
Portsmouth, UK.
Aims: To compare the cost effectiveness of our department's predomi-
nantly duplex ultrasound (DUS) based post-EVAR surveillance program
with that recommended by the European Society of Vascular Surgery
guideline that relies more heavily on CT angiogram (CTA) surveillance.
Methods: The clinical records and surveillance imaging of 100 consecutive
patients post-EVAR were reviewed. The total cost of imaging they received
during the follow up period was compared with the total cost of imaging
according to ESVS guidelines. The 2012/13 NHS cost tariffs for CTA (£130/
scan) and DUS (£47/scan) were used.
Results: Over ﬁve years follow up, 417 episodes of imaging occurred (252
DUS, 165 CTA). Use of CTA decreased from 99% at one-month follow up to
33% at one year. Thereafter up to 27% of patients required CTA at any
subsequent follow up. Total cost of imaging in our program was £33,294
(CTA: £21,450, DUS £11,844). The ESVS guidelines were applied to our data
set. This hypothetical scenario would have cost £35,792 comprising 237
CTA (£30,810) and 106 DUS (£4,982). Our DUS surveillance program saved
£2,498 over 5 years.
Conclusions: CTA surveillance is more expensive than DUS post EVAR
even when shorter DUS surveillance intervals are used.
0249: GREATER THAN TEN-YEAR OUTCOMES FOLLOWING ENDOVASCU-
LAR ANEURYSM REPAIR
Laura Warner 2, Hannah Sevenoaks 1, Jonathan Ghosh 1. 1University
Hospitals of South Manchester, Manchester, UK; 2North Western Deanery,
North West, UK.
Aims: Endovascular aneurysm repair (EVAR) offers improved periopera-
tive morbidity and mortality compared to open repair, counterbalanced by
a higher incidence of graft-related complications and re-interventions.
Randomised studies comparing EVAR to open repair are yet to report
greater than ten-year outcomes. This study reports the outcomes of pa-
tients who underwent EVAR with ﬁrst generation endografts greater than
ten years ago.
Methods: Retrospective review of prospectively collected data of all pa-
tients who underwent EVAR between 1997 and 2001, supplemented with
case note review, interrogation of imaging and correspondence with
general practitioners and coroners' ofﬁces.
Results: 58 patients underwent EVAR. Technical success was 100% and 30-
day mortality was 0%. The re-intervention rate was 27.3%, including 5
elective open conversions, 2 emergency open repairs, 5 embolizations, and
3 extensions. Median time to re-intervention was 30 months (1-144). Four
patients died from ruptured AAA.
Conclusions: Stable long-term aneurysm exclusion was achieved in the
majority of patients. Virtually all re-interventions were performed within
50 months. Whilst life-long surveillance should be continued, these data
raise the question of the appropriate duration of CT surveillance and
suggests that EVAR should be considered for patients with longer life ex-
pectancy and favourable anatomy who traditionally would have under-
gone open repair.
0270: POST-OPERATIVE MANAGEMENT OF DIABETIC PATIENTS
REQUIRING MAJOR AMPUTATION IS MORE CHALLENGING THAN THOSE
HAVING OPEN ABDOMINAL AORTIC ANEURYSM SURGERY (AAA)
Mohamed Barkat, Nathan Appleton, Rajesh Chatha, Colin Chan. Wirral
University Teaching Hospital NHS Foundation Trust, Wirral, UK.
Aim: In-hospital mortality rates for patients undergoing diabetic foot
surgery range from 9% (National Vascular Database) to 17% (Hospital
Episode Statistics data). This compares unfavourably with 4% for that of
open AAA surgery. Our aim was to evaluate outcomes following major
diabetic foot amputations in a district general hospital.
Method: A retrospective case note review of consecutive patients under-
going major amputation for diabetic foot complications over a three year
period.
Results: Between August 2009 to August 2011, 75 patients underwent
major amputations: (50% trans-femoral, 42% trans-tibial and 8% other).
